Go Ad-Free
My Alerts
VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
MARKETS

Strides Pharma Science Ltd.

BSE: 532531 | NSE: STAR |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE939A01011 | SECTOR: Pharmaceuticals & Drugs

| BSE 859.80 -5.80 (-0.67%) | |

BSE Live

Feb 13, 16:01
859.80 -5.80 (-0.67%)
Volume
AVERAGE VOLUME
5-Day
6,511
10-Day
13,618
30-Day
27,420
4,207

  • Prev. Close

    865.60

  • Open Price

    860.30

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 13, 15:58
857.65 -8.10 (-0.94%)
Volume
AVERAGE VOLUME
5-Day
217,612
10-Day
332,267
30-Day
539,911
180,227

  • Prev. Close

    865.75

  • Open Price

    867.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    857.65 (27)

Financials

Cash Flow of Strides Pharma Science (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 151.86 108.33 915.80 182.65 189.29  
Net CashFlow From Operating Activities 148.84 39.97 65.59 411.74 83.56  
Net Cash Used In Investing Activities 50.88 -166.06 447.36 -344.05 -1,064.38  
Net Cash Used From Financing Activities -203.56 123.26 -706.77 -67.24 1,570.84  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 -14.40 -538.77 1.93  
Net Inc/Dec In Cash And Cash Equivalents -3.84 -2.83 -208.22 -538.32 591.96  
Cash And Cash Equivalents Begin of Year 69.47 72.30 280.52 818.84 225.82  
Cash And Cash Equivalents End Of Year 65.63 69.47 72.30 280.52 817.78  
Source : Dion Global Solutions Limited

Results of Strides Pharma

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Parallel Income Plan 2026